• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种预防恶性胸腔积液复发的新方法:早期胸膜固定术。

A novel approach for preventing recurrence of malign pleural effusion: early phase pleurodesis.

作者信息

Cobanoglu Ufuk, Kemik Ozgur, Celik Sebahattin, Sayir Fuat

机构信息

Department of Thoracic Surgery, University of Yuzuncu Yil, Van, Turkey.

Department of Surgical Oncology, University of Yuzuncu Yil, Van, Turkey.

出版信息

Arch Med Sci. 2018 Oct;14(6):1404-1415. doi: 10.5114/aoms.2017.72543. Epub 2018 Jan 4.

DOI:10.5114/aoms.2017.72543
PMID:30393496
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6209722/
Abstract

INTRODUCTION

The effective control of malignant pleural effusion (MPE) is of paramount importance in the treatment of patients with disseminated cancer. In this study, we compared two different approaches (early pleurodesis versus late pleurodesis) to MPE.

MATERIAL AND METHODS

Patients (188 cases) whose primary tumor type was known and who were confirmed to have MPE, were included in the study and were separated into two groups. One group consisted of patients who were asymptomatic and who underwent early phase pleurodesis (group I, = 79). The other group (group II, = 109) was composed of patients who were symptomatic and whose pleurodesis was performed later. In all cases, pleural effusion was evaluated by means of direct radiography. Computed tomography was performed with the goal of confirming the parenchymal or mediastinal lesions accompanying the pleural fluid.

RESULTS

The rate of complete success in group I cases was observed to be higher, while the rate of recurrence was lower ( = 0.001 and = 0.002, respectively) than group II. In multiple logistic regression analysis, co-morbidities and the group that patient belong were found to be significant in terms of pleurodesis success ( = 0.02 and = 0.03). There was a significant difference in survival time between group I and group II, with group I exhibiting longer average survival time (log rank test < 0.001).

CONCLUSIONS

We observed that the success rate was lower and the rate of recurrence higher in the late pleurodesis group, whose members already had greater volumes of pleural effusion.

摘要

引言

有效控制恶性胸腔积液(MPE)在播散性癌症患者的治疗中至关重要。在本研究中,我们比较了两种不同的MPE治疗方法(早期胸膜固定术与晚期胸膜固定术)。

材料与方法

本研究纳入了188例原发性肿瘤类型已知且确诊为MPE的患者,并将其分为两组。一组由无症状且接受早期胸膜固定术的患者组成(第一组,n = 79)。另一组(第二组,n = 109)由有症状且其胸膜固定术在更晚时候进行的患者组成。在所有病例中,通过直接放射成像评估胸腔积液。进行计算机断层扫描以确认伴随胸腔积液的实质或纵隔病变。

结果

观察到第一组病例的完全成功率更高,而复发率低于第二组(分别为P = 0.001和P = 0.002)。在多因素逻辑回归分析中,发现合并症和患者所属组在胸膜固定术成功方面具有显著意义(P = 0.02和P = 0.03)。第一组和第二组之间的生存时间存在显著差异,第一组的平均生存时间更长(对数秩检验P < 0.001)。

结论

我们观察到晚期胸膜固定术组的成功率较低且复发率较高,该组患者已经有更大体积的胸腔积液。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ce4/6209722/6b9be588c896/AMS-14-31426-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ce4/6209722/273266b01e1b/AMS-14-31426-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ce4/6209722/9a62777ec1fa/AMS-14-31426-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ce4/6209722/34768eea2845/AMS-14-31426-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ce4/6209722/773a2f5709ff/AMS-14-31426-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ce4/6209722/c5fb51b715b0/AMS-14-31426-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ce4/6209722/6b9be588c896/AMS-14-31426-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ce4/6209722/273266b01e1b/AMS-14-31426-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ce4/6209722/9a62777ec1fa/AMS-14-31426-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ce4/6209722/34768eea2845/AMS-14-31426-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ce4/6209722/773a2f5709ff/AMS-14-31426-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ce4/6209722/c5fb51b715b0/AMS-14-31426-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ce4/6209722/6b9be588c896/AMS-14-31426-g006.jpg

相似文献

1
A novel approach for preventing recurrence of malign pleural effusion: early phase pleurodesis.一种预防恶性胸腔积液复发的新方法:早期胸膜固定术。
Arch Med Sci. 2018 Oct;14(6):1404-1415. doi: 10.5114/aoms.2017.72543. Epub 2018 Jan 4.
2
Bevacizumab plus chemotherapy in nonsquamous non-small cell lung cancer patients with malignant pleural effusion uncontrolled by tube drainage or pleurodesis: A phase II study North East Japan Study group trial NEJ013B.贝伐珠单抗联合化疗治疗恶性胸腔积液经引流或胸膜固定术控制不佳的非鳞状非小细胞肺癌患者:东北日本研究组试验 NEJ013B 的 II 期研究。
Thorac Cancer. 2020 Jul;11(7):1876-1884. doi: 10.1111/1759-7714.13472. Epub 2020 May 18.
3
Talc pleurodesis as surgical palliation of patients with malignant pleural effusion. Analysis of factors affecting survival.滑石粉胸膜固定术作为恶性胸腔积液患者的姑息性手术。影响生存的因素分析。
Anticancer Res. 2012 Nov;32(11):5071-4.
4
Can EGFR-Tyrosine Kinase Inhibitors (TKI) Alone Without Talc Pleurodesis Prevent Recurrence of Malignant Pleural Effusion (MPE) in Lung Adenocarcinoma.表皮生长因子受体-酪氨酸激酶抑制剂(TKI)单独使用而不进行滑石粉胸膜固定术能否预防肺腺癌恶性胸腔积液(MPE)复发?
Curr Drug Discov Technol. 2016;13(2):68-76. doi: 10.2174/1570163813666160524142846.
5
Subcutaneous octreotide therapy for malignant pleural effusion after pleurodesis with talc powder: a placebo-controlled, triple-blind, randomized trial.滑石粉胸膜固定术后皮下奥曲肽治疗恶性胸腔积液:一项安慰剂对照、三盲、随机试验。
Support Care Cancer. 2022 Dec;30(12):9833-9840. doi: 10.1007/s00520-022-07440-5. Epub 2022 Nov 11.
6
Interventions for the management of malignant pleural effusions: a network meta-analysis.恶性胸腔积液管理的干预措施:一项网状Meta分析
Cochrane Database Syst Rev. 2020 Apr 21;4(4):CD010529. doi: 10.1002/14651858.CD010529.pub3.
7
Pleural fluid osteopontin, vascular endothelial growth factor, and urokinase-type plasminogen activator levels as predictors of pleurodesis outcome and prognosticators in patients with malignant pleural effusion: a prospective cohort study.恶性胸腔积液患者胸膜固定术结局预测指标及预后因素:血清骨桥蛋白、血管内皮生长因子和尿激酶型纤溶酶原激活物水平的前瞻性队列研究
BMC Cancer. 2016 Jul 13;16:463. doi: 10.1186/s12885-016-2529-1.
8
Talc pleurodesis improves survival of patients with malignant pleural effusions: case-control study.滑石粉胸膜固定术可提高恶性胸腔积液患者的生存率:病例对照研究。
Wien Klin Wochenschr. 2015 Dec;127(23-24):963-9. doi: 10.1007/s00508-015-0716-8. Epub 2015 Apr 10.
9
Thoracic Ultrasound as an Early Predictor of Pleurodesis Success in Malignant Pleural Effusion.胸腔超声在恶性胸腔积液胸膜固定术中的早期预测价值。
Chest. 2018 Nov;154(5):1115-1120. doi: 10.1016/j.chest.2018.08.1031. Epub 2018 Sep 20.
10
Role of thoracic ultrasonography in pleurodesis pathways for malignant pleural effusions (SIMPLE): an open-label, randomised controlled trial.胸部超声在恶性胸腔积液胸膜固定术路径中的作用(SIMPLE):一项开放标签、随机对照试验
Lancet Respir Med. 2022 Feb;10(2):139-148. doi: 10.1016/S2213-2600(21)00353-2. Epub 2021 Oct 8.

本文引用的文献

1
Novel hematological biomarkers predict survival in renal cell carcinoma patients treated with nephrectomy.新型血液生物标志物可预测接受肾切除术治疗的肾细胞癌患者的生存率。
Arch Med Sci. 2017 Sep 21;16(5):1062-1071. doi: 10.5114/aoms.2017.70250. eCollection 2020.
2
[Imaging of pleural diseases: evaluation of imaging methods based on chest radiography].[胸膜疾病的影像学检查:基于胸部X线摄影的成像方法评估]
Tuberk Toraks. 2017 Mar;65(1):41-55. doi: 10.5578/tt.47546.
3
Predictors of talc slurry pleurodesis success in patients with malignant pleural effusions.
恶性胸腔积液患者滑石粉浆胸膜固定术成功的预测因素。
Rev Port Pneumol (2006). 2017 Jul-Aug;23(4):216-220. doi: 10.1016/j.rppnen.2017.01.008. Epub 2017 Jun 9.
4
Marginal zone B-cell lymphoma mimicking extramedullary plasmacytoma and the clinical outcome after treatment.模仿髓外浆细胞瘤的边缘区B细胞淋巴瘤及治疗后的临床结局
Arch Med Sci. 2017 Apr 1;13(3):698-701. doi: 10.5114/aoms.2017.67290. Epub 2017 Apr 20.
5
Diagnosis and management options in malignant pleural effusions.恶性胸腔积液的诊断与处理方法
Lung India. 2017 Mar-Apr;34(2):160-166. doi: 10.4103/0970-2113.201305.
6
Pleural procedures in the management of malignant effusions.胸膜操作在恶性胸腔积液管理中的应用
Ann Thorac Med. 2017 Jan-Mar;12(1):3-10. doi: 10.4103/1817-1737.197762.
7
Intraoperative diagnosis of sentinel lymph node metastases in breast cancer treatment with one-step nucleic acid amplification assay (OSNA).一步核酸扩增检测法(OSNA)在乳腺癌治疗中对前哨淋巴结转移的术中诊断
Arch Med Sci. 2016 Dec 1;12(6):1239-1246. doi: 10.5114/aoms.2016.62902. Epub 2016 Oct 24.
8
[The differential diagnosis of pleural effusions].[胸腔积液的鉴别诊断]
Vnitr Lek. 2016 Fall;62(7-8):598-604.
9
Malignant pleural effusion: from bench to bedside.恶性胸腔积液:从实验台到病床边
Eur Respir Rev. 2016 Jun;25(140):189-98. doi: 10.1183/16000617.0019-2016.
10
Interventions for the management of malignant pleural effusions: a network meta-analysis.恶性胸腔积液管理的干预措施:一项网状荟萃分析。
Cochrane Database Syst Rev. 2016 May 8;2016(5):CD010529. doi: 10.1002/14651858.CD010529.pub2.